Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

New Chocolate-Flavored Dr. Cocoa™ for Children, a Patented OTC Cough/Cold Line, Fights the Cold Symptoms, Not the Child

First-Ever Children's Cough and Cold Patented Medicines to Combine Trusted, Effective Ingredients with Real Cocoa for a Chocolate Flavor to Help Improve Dosing Compliance


News provided by

Dr. Cocoa for Children

Sep 16, 2014, 08:03 ET

Share this article

Share toX

Share this article

Share toX

WESTPORT, Conn., Sept. 16, 2014 /PRNewswire/ -- In a new national survey1 of U.S. parents of school-age children (ages 4-13), almost 40% report that it isn't always easy to give their children over-the-counter liquid cough/cold medicines. One third (34%) of parents believe the taste of the medicine impacts how easy it is to give their child the recommended dose, with one in four (24%) saying their child often complains that liquid medicines taste bad. Like these parents, infirst Healthcare knows that taste matters, so they are providing a new solution with the launch of their new Dr. Cocoa™ for Children brand.  It's the first-ever line of patented over-the-counter cough and cold medicines formulated with trusted, effective ingredients and 10% real cocoa for real chocolate taste to improve compliance.

Continue Reading
New Dr. Cocoa(TM) for Children provides cough and cold relief ... with a smile.  Dr. Cocoa(TM) for Children is the first-ever cough and cold medicine for kids made with trusted, effective ingredients and 10% real cocoa for a real chocolate taste. Available in three patented formulas: Dr. Cocoa(TM) Long-Acting Cough Relief, Dr. Cocoa(TM) Daytime Cough Cold Relief, and Dr. Cocoa(TM) Nighttime Cough Cold Relief. Visit www.drcocoa.com and connect with us at www.facebook.com/DrCocoaforChildren (PRNewsFoto/Dr. Cocoa for Children)
New Dr. Cocoa(TM) for Children provides cough and cold relief ... with a smile. Dr. Cocoa(TM) for Children is the first-ever cough and cold medicine for kids made with trusted, effective ingredients and 10% real cocoa for a real chocolate taste. Available in three patented formulas: Dr. Cocoa(TM) Long-Acting Cough Relief, Dr. Cocoa(TM) Daytime Cough Cold Relief, and Dr. Cocoa(TM) Nighttime Cough Cold Relief. Visit www.drcocoa.com and connect with us at www.facebook.com/DrCocoaforChildren (PRNewsFoto/Dr. Cocoa for Children)

"Our mission is to make known, safe and effective medicines better. With Dr. Cocoa we are making effective cough and cold medicines better for kids and their parents with real chocolate flavor," says James Barickman, General Manager at infirst Healthcare USA. "Taste is important to compliance among children, and many parents struggle with getting their children to take medicine as directed. Dr. Cocoa's soothing real-cocoa formula was developed to improve on this issue among children – it triggers a smile, not a struggle."

A clinical palatability study among 50 pediatric patients showed that on average the taste of Dr. Cocoa was rated as good2. "The pediatric participants confirmed that the taste is good and hence is not a compliance barrier. Purposefully the product is not designed to be perceived as 'really good' as flavor should support compliance but for a medicine not be exceedingly appealing," adds Barickman.
Dye-, alcohol- and gluten-free, the new Dr. Cocoa™ line is available in three formulas that combine trusted, effective ingredients with 10% real cocoa for a real chocolate flavor:

  • Dr. Cocoa™ for Children Long-Acting Cough Relief is for the non-drowsy, temporary relief of coughing due to minor throat and bronchial irritations as may occur with a cold. Intended for use in children ages 4 -13. Carefully follow the instructions for dosing on the box using the enclosed measuring spoon. (Active ingredient:  Dextromethorphan)
  • Dr. Cocoa™ for Children Daytime Cough+Cold Relief is for the non-drowsy, temporary relief of cough due to minor throat and bronchial irritation as may occur with a cold, along with nasal congestion.  Indicated for use in children ages 4-13; use in children under the age of 6 should be on the advice of a doctor.  Carefully follow the instructions for dosing on the box using the enclosed measuring spoon (Active ingredients: Dextromethorphan, Phenylephrine) 
  • Dr. Cocoa™ for Children Nighttime Cough+Cold Relief temporarily relieves sneezing, itchy nose or throat, cough due to minor throat and bronchial irritation as may occur with a cold, nasal congestion, runny nose, and itchy, watery eyes, while helping your child to rest.  Intended for use in children ages 6-13. Carefully follow the instructions for dosing on the box using the enclosed measuring spoon. (Active ingredients: Diphenhydramine, Phenylephrine)

Dr. Cocoa™ for Children is available online at drugstore.com and available on shelves at all major food, drug, and mass merchant retailers nationwide. For more information, visit www.drcocoa.com, or to connect with the brand, visit www.facebook.com/DrCocoaforChildren.

Dr. Cocoa™ for Children is owned and distributed by infirst Healthcare Inc., a subsidiary of U.K.-based infirst Healthcare Ltd., a company determined to bring meaningful innovation for everyday ailments to consumer healthcare and primary care practitioners.  infirst Healthcare believes that more effective treatments can be found by taking known drugs and making them better to increase patient compliance and improve outcomes.      

*Although Dr. Cocoa™ tastes good, it is an FDA-regulated medicine. Use as directed, and keep this and all medicines safely out of the reach of children. For specific questions about dosing or formulations, please speak with a pediatrician.

1Survey was conducted online within the United States between May 2-6, 2014 among 2,049 adults aged 18 and older, of whom 293 are parents of children age 4-13, by Harris Poll on behalf of infirst Healthcare via its Quick Query omnibus product. Figures for age, sex, race/ethnicity, education, region and household income were weighted where necessary to bring them into line with their actual proportions in the population. Propensity score weighting was used to adjust for respondents' propensity to be online.

2 Taste rated on a 5 point scale, [1= really bad, 2=bad, 3=not sure, 4=good, 5=really good]. Dr. Cocoa achieved a mean rating of 4.14. Pediatric Taste Study (2013); conducted among 50 patients, ages 6-13; 8-hour cough formulation tested. Clinical Study Administrators: Radian Research, Pinellas Park, FL; Methodology: "The Standard Guide for Sensory Evaluations of Products by Children"; ASTM Designation: E2299-11

Photo - http://photos.prnewswire.com/prnh/20140912/145904

SOURCE Dr. Cocoa for Children

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.